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Abstract The major regulators of melanogenesis are glyco-
proteins, however no role for glycosylation in the pathway has
yet been described. We stained skin biopsies and melanocyte-
keratinocyte co-cultures with a panel of 20 lectins as oligosac-
charide markers. Notably, the Elderberry Bark Lectin (EBL/
SNA) stained melanocytes in both systems. EBL binds the
sequenceNeu5Ac(α(2-6)Gal/GalNAc)- at the termini of some
oligosaccharide antennae.We used inhibitors of synthesis and/
or binding of this sequence to assess effects on pigmentation.
METHODS. Cell culture, lectin histochemistry, siRNA trans-
fection, and assays for dopa oxidase and melanin were carried
out by standard techniques. RESULTS. 6′-sialyllactose, a
short homolog of the sequence in question, anti-
sialyltransferase 6 (ST6) siRNA, and cytidine, a
sialyltransferase (ST) inhibitor, each inhibited EBL binding,
melanogenesis and melanosome transfer. Unexpectedly, 3′-
sialyllactose and siRNA for ST3, chosen as a negative con-
trols, also inhibited these processes. Though strong inhibitors
of melanization, none of the agents affected tyrosinase/dopa
oxidase activity, indicating previously unrecognized post-
tyrosinase regulation of melanization. CONCLUSIONS. We
report for the first time that Neu5Ac (α(2-6)Gal/GalNAc)- and
possibly Neu5Ac(α(2–3)Gal/GalNAc)-terminated oligosac-
charides play multiple roles in melanin synthesis and transfer.
Keywords Sialyl conjugates . Melanocyte . Keratinocyte .
Melanin transfer . Skin pigmentation
Introduction
Melanosome transfer from melanocytes to keratinocytes is a
unique biological process involving organelle donation from
one cell to another and a crucial step in skin pigmentation.
Individuals with defects in transfer can have markedly re-
duced skin melanin content [1–3]. Melanosome transfer be-
gins with attachment of melanocyte dendrites to keratinocytes
followed by transfer of melanosomes through the melanocyte
dendrites into the keratinocytes and finally trafficking of the
melanin within keratinocytes to the supra-nuclear area of the
cell. There is growing information on melanocyte-
keratinocyte transfer regarding cell biology, cytokine and hor-
monal signaling pathways and the role of various peptides and
proteins [4–8]. However, while the major protein regulators
are glycoproteins, little is known about the roles of glycosyl-
ation in the process. Accordingly, we assembled a panel of 20
biotinylated lectins asmarkers for specific glycosylation struc-
tures and used lectin histochemistry to analyze staining pat-
terns in biopsies of human skin and co-cultures of human
melanocytes and keratinocytes. The Elderberry Bark lectin
(EBL) showed specific staining of melanocytes and highlight-
ed melanocyte dendrites. Here we report on the EBL binding
site and its roles in melanin synthesis and transfer.
Experimental results
Lectin binding studies in cutaneous biopsies While most of
the 20 lectins studied showed no specific staining of melano-
cytes, EBL was notable because it strongly stained
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melanocytes compared to other cells in the epidermis, with
prominent labeling of dendrites. EBL recognizes the terminal
Neu5Ac(α(2-6)Gal/GalNAc)- sequence on certain glycans.
The same staining patterns were seen in biopsies from indi-
viduals of a variety of ethnic backgrounds and skin colors (not
shown).
Histological sections of skin biopsies were stained
with EBL and as a control the MAAII lectin (Maackia
amurensis L.) that had shown little or no staining of
melanocytes in the 20-lectin survey above. MAAII rec-
ognizes the Neu5Ac(α(2-3)Gal/GalNAc)- sequence.
While EBL again stained melanocyte dendrites emanat-
ing from the cell body (Fig. 1a), the MAAII lectin did
not (Fig. 1b). These findings demonstrated the specific-
ity of the EBL lectin and the Neu5Ac(α2-6)Gal/
GalNAc- sequence for melanocytes.
EBL binding in melanocyte-keratinocyte co-cultures We
next investigated EBL staining in co-cultures of human
melanocytes and keratinocytes, in this case with a red
chromagen. Melanocytes were identified in culture by
their dark pigmentation and elongated dendrites.
Keratinocytes were non-pigmented with punctate den-
drites. Figure 2a shows a melanocyte in contact with
a keratinocyte. The melanocyte plasma membrane, in-
cluding dendrites, stains strongly with EBL. At points
of contact with the keratinocyte, the melanocyte den-
drite extends numerous filapodia that also stain with
EBL (blue asterisk). A higher power view is shown
in Fig. 2b. This close association indicated that oligo-
saccharides terminated with Neu5Ac(α(2-6)Gal/
GalNAc)- are likely to function in melanosome
transfer. Interestingly, Neu5Ac(α(2-6)Gal/GalNAc)- is
the terminal sequence for some membrane-associated
glycoconjugates in various biological systems [9]. Syn-
thesis of this sequence is catalyzed by β-galactoside
(α2,6)-Sialyltransferase 6 (ST6Gal.I) that catalyzes for-
mation of Neu5Ac(α2-6)Gal/GalNAc- terminus of some
N- and O-linked oligosaccharides. Binding is highly
specific, as the EBL discriminates between the
Neu5Ac(α(2–6)Gal/GalNAc)- sequence and the related
Fig. 1 Histochemical staining of
melanocytes from sequential
sections of the same skin biopsy.
Sections were stained through
standard immunoperoxidase
methods using a brown
chromagen. Counter-staining was
with hematoxylin (blue). a. A
section stained with EBL lectin
showing brown staining of
melanocytes. b. A sequential
section stained with MAAII
lectin. Melanocyte nuclei are
marked with white asterisks
Fig. 2 A photograph of a melanocyte in contact with a keratinocyte in
co-culture. Cultures were stained with EBL by standard histochemical
techniques using a red chromagen and photographed through a Zeiss
light microscope (see BMaterials and Methods^). a. Low power photo
showing EBL staining of melanocyte plasma membrane. b. High power
of the filapodial contact points (blue asterisk)
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Neu5Ac(α2-3)Gal/GalNac- sequence recognized by
MAAII due to steric hindrance [10, 11]. These results
demonstrate that the Neu5Ac(α(2-6)Gal/GalNAc)- se-
quence is at the terminus of glycans on melanocyte
dendrites, where it is likely to be involved with mela-
nosome transfer to keratinocytes.
Involvement of Neu5Ac(α(2-6)Gal/GalNAc)- linkages
and ST6Gal.I represent a previously unrecognized regu-
latory point in the pigmentation pathway. Interestingly,
sialylated oligosaccharides are functional in biological
recognition systems involving cell-cell recognition and
at tachment [9] . Since melanosome transfer to
keratinocytes is a rate-limiting step in skin pigmenta-
tion, this suggests that disruption of Neu5Ac(α2-6)Gal/
GalNAc-oligosaccharide synthesis and/or function might
inhibit melanosome transfer.
Inhibition of EBL binding in melanocyte-keratinocyte co-
cultures There are more than 20 sialyltransferases in
humans and sialyltransferase inhibitors have been re-
ported [9].To determine the oligosaccharide sequence
recognized by EBL, Shibuya et al. [9] reported a num-
ber of short oligosaccharides that showed inhibition of
EBL-mediated precipitation of glycophorin, a highly
sialylated glycoprotein. They deduced that the EBL lec-
tin showed the highest affinity for oligosaccharides con-
taining the Neu5Acα(2–6)Gal/GalNAc- sequence. We
reasoned that this or similar structures might be useful
targets for inhibiting melanocyte functions involving
Neu5Acα(2–6)Gal/GalNAc-containing oligosaccharides.
We thus tested for inhibitors that might affect melano-
cytes and keratinocytes in co-culture: 1) cytidine, a
small molecule sialyltransferase (ST) inhibitor; 2) short
sialylated oligosaccharides as competitive inhibitors of
melanocyte-keratinocyte interactions, and 3) specific
siRNAs vs the sialyltransfereases ST6 and ST3. None
of these treatments affected cell survival (not shown).
The results are detailed below.
Effects of L-cytidine on EBL binding in melanocyte-
keratinocyte co-cultures Experiments were carried out
to test the effects of cytidine, an ST6Gal.I inhibitor (,
on EBL staining in melanocyte-keratinocyte co-cultures
(Fig. 3a and b). Untreated cultures showed prominent
EBL staining of melanocyte dendrites, including
filapodia in contact with keratinocytes (Fig. 3a). Treat-
ment with cytidine markedly reduced EBL staining
(Fig. 3b).
Effects of short sialylated oligosaccharides as competitive
apteninhibitors of EBL function We next tested 6′-
sialyllactose(Neu5Acα(2–6)Gal/GalNAcβ(1−4)Glc; 3′
SL)Glc; 6′-SL) an oligosaccharide homologue of the
EBL recognition sequence and a strong inhibitor of
EBL-mediated precipitation of glycophorin [9, 10]. As
a control, cultures were incubated with 3′-sialyllactose
(Neu5Acα(2–3)Gal/GalNacβ(1−4)Glc; 3′SL)Glc; 3′SL) that
does not interact with the EBL binding site due to steric
hindrance, and consequently is a poor inhibitor of EBL-
mediated precipitation of glycophorin [9, 10]. Cultures
were incubated for 72 h with each agent, the cells were
pelleted by centrifugation, and melanin was solubilized
and quantitated through spectrophotometry. Unexpected-
ly, both oligosaccharides individually reduced melanin
content compared to that in untreated cultures, and 3′-
SL consistently gave the strongest reduction of the two
(Fig. 4). This was surprising since 3′-SL is a poor com-
petitor for EBL binding, as discussed above [9, 10]. Sim-
ilarly, when melanocyte-keratinocyte co-cultures were
stained for melanin with the Fontana-Masson silver stain-
ing procdure. 6′-SL and 3′-SL each reduced melanin con-
tent in melanocytes-keratinocyte co-cultures (not shown).
Fig. 3 Effects of L-cytidine [25 μM] on EBL staining and melanin
content of human melanocyte-keratinocye co-cultures. Cultures were
incubated 72 h with L-cytidine (25 μM), rinsed in BSS, fixed with
paraformaldehyde, rinsed again with BSS and stained with EBL (red
chromagen) using standard IHC procedures. Counterstaining was with
hematoxylin (blue). Random fields were photographed with a Zeiss
Axioskop 40 light microscope equipped with a Spot Flex digital
camera. Using Photoshop tools, dendrites were cut and pasted into the
treatment groups herein. The composite images were then enhanced
together with automatic contrast and brightening tools. a. Untreated
controls; b. EBL stained
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Therefore, melanogenesis within melanocytes and trans-
fer of melanosomes into keratinocytes were each
inhibited by these agents.
Effects of 6′-SL and 3′-SL in combination with cytidine on
melanin content in human melanocyte-keratinocyte co-
cultures Dose response studies were carried out on
melanocyte-keratinocyte co-cultures to compare the in-
hibitory activities of 6′-SL, 3′-SL and cytidine, as single
agents and in combinations, on melanin content and
tyrosinase activity. All categories caused highly signifi-
cant reductions in melanin content at all concentrations
tested (5–40 μM) (Fig. 6; Table 1). In some cases,
treatments prevented new melanin synthesis during the
72 h experiment, i.e., melanin above the t0 level at the
beginning of the experiment (red line). In others, not
only was new melanin prevented but, surprisingly, re-
duced below that seen at the t0 level during the 72 h
experiment (Fig. 5b, red line), implying that these treat-
ments caused melanin degradation and/or release to the
culture medium. Cell viability was not affected by these
treatments (not shown). The percent inhibition at each
concentration was compared and analyzed for Bliss Ad-
ditivity, i.e., significantly the same as the sum of the
two agents alone While many of the treatments indeed
showed Bliss Additivity, others showed synergism, i.e.,
inhibition significantly above that expected for Bliss
Additivity. Synergism was seen in the combinations of
3′-SL+6′-SL (5+5 μM, 10+10 μM, 15+15 μM); 3′-
SL+cytidine (15+15 μM); and 6′-SL+cytidine (15+
15 μM), with p-values ranging from p=≤0.01 to p=≤
0.06 (Fig. 6a, red asterisks). In the same samples none
of the agents significantly reduced tyrosinase activity
(Fig. 6b). The results indicate that the inhibitors re-
duced melanin content by targeting post-tyrosinase path-
ways, possibly through interference with glycosylation
processes.
The minimal doses for >80 % reduction of melanin content
were determined for each treatment category. The combina-
tion of 6′-SL+3′-SL was the most effective, causing ~85 %
Table 1 P-Value Tests: treated vs untreated control






























P-values were determined by the Welch Two Sample t-test
Fig. 4 Effects of L-cytidine (Cyt, 50 μM), 6′-sialyllactose (6′-SL,
50 μM) and 3′-sialyllactose (3′-SL, 50 μM) on melanin content of
human melanocyte-keratinocye co-cultures compared to an untreated
control (UT). Cultures were incubated 72 h with each agent, pelleted by
centrifugation, and melanin was solubilized for quantitation via
spectrophotometry. Original images were produced with a Zeiss
Axioskop 40 light microscope equipped with a Spot Flex digital
camera. All images were enhanced together with automatic contrast and
brightening tools
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inhibition at the combined concentration of 5 μM+5 μM, 3-
fold more active than that in any other category (Fig. 6a,
Table 2).
Effects of cytidine, 6′-SL, 3′-SL on melanin transfer The
effects on melanocyte-keratinocyte melanosome transfer were
assessed after treatment with cytidine, 3′-SL, and 6′-SL alone
and in combination (Fig. 7a and b). Untreated co-cultures had
highly melanized melanocytes surrounded by keratinocytes. The
melanocytes had close contacts with neighboring keratinocytes
over large portions of the plasma membranes. The keratinocytes
in direct contact with the melanocyte (nuclei with yellow aster-
isks) contained numerous cytoplasmic melanin granules trans-
ferred from themelanocyte. Keratinocytes not in contact with the
melanocyte (nuclei with red asterisks) contained notably fewer
melanosomes (Fig. 7a). In contrast a representative field from a
co-culture treated with the combination of 3′-SL+cytidine
showed a marked reduction in melanocyte-keratinocyte contacts
and a reduction of melanosomes in both cell types (Fig. 7b). All
treatment categories showed these effects, but since transfer is a
dynamic process it could not be quantitated in the fixed cultures
studied herein.
Transfection of siRNAs for ST6 and ST3 When ST6 and
ST3 siRNAs were transfected into mouse melan-A cells, both
EBL binding (Fig. 8a) and melanin content (Fig. 8b) were
strongly inhibited by ST6 siRNA and to a lesser extent by
ST3 siRNA.
Discussion and conclusions
Together, these findings demonstrate for the first time that
Neu5Acα(2-6)Gal- and possibly sialyl(α2-3)gal-terminated
glycans play key roles in melanin synthesis and melanosome
transfer to keratinocytes. The structures are prominently
expressed on melanocyte dendrites where they are closely asso-
ciated with the transfer of melanosomes to keratinocytes, a rate-
limiting step in skin pigmentation. While it is likely that the
glycans are glycoproteins, at this point we cannot rule out the
possibilities of glycolipids or proteoglycans, nor do we know if
the oligosaccharide is N- or O-linked in the glycoconjugate.
Excess or uneven skin pigmentation such as seen in
melasma, post-inflammatory hyperpigmentation and so-
lar lentigenes can cause severe anxiety and depression
in affected individuals. These findings point to new pos-
sibilities for reducing hyperpigmentation through inhibi-
tion of the synthesis and function of oligosaccharides
regulating the pigmentary system.
Fig. 5 Melanin content (a) and tyrosinase activity (b) in melanocyte-
keratinocyte co-cultures. The red line indicates the t0 levels at initiation
of the experiment. Cases where melanin content was significantly greater
than that expected for Bliss Additivity are indicated by (*) (p=≤0.06);
(**) (p=≤0.01)
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Materials and methods
Cell culture Primary neonatal normal human keratinocytes
(NHKs) (Invitrogen, Life Technologies, Grand Island, NY)
were seeded at a density of 5×105 cells/well into 4-well col-
lagen coated chamber slides (Fisher Scientific, Waltham,
MA). Cells were maintained in 1 ml of serum-free
keratinocyte growth medium (KGM) (Keratinocyte-SFM,
Invitrogen) and incubated for 48 h in 5 % CO2 incubator.
Darkly pigmented human neonatal epidermal melanocytes
(HEM-DP) (Invitrogen) were seeded over the keratinocytes
at 2.5×105 cells/well and incubated 24 h, 37o C. The KGM
was then replaced with 1 ml of melanocyte growth medium
(MGM) (Invitrogen), and the co-cultures were incubated for
another 48 h. The co-cultures were then treated with the in-
hibitors at indicated concentrations in a final volume of 20 μl/
well in triplicate for 72 h. The cells were then gently rinsed
with 1× phosphate buffered saline (PBS) and fixed in 4 %
Para-formaldehyde (PFA) for 20′ at room temperature.
Lectin histochemistry Cells fixed in 4 % PFAwere washed
in 1× PBS and incubated for 10′ at RT in a dual enzyme block
solution (Dako, Glostrop, Denmark) followed by wash in 1×
PBS, and then incubated with protein block solution for 10′ at
RT. The cells were then incubated with biotinylated elderberry
Fig. 7 Effects of cytidine in combination with 3′-SL on melanocyte-
keratinocyte interactions and melanosome transfer. Cells were incubated
72 h with cytidine+3′-SL, fixed in paraformaldehyde, stained for melanin
with the Fontana-Masson silver stain. Images were photographed at
magnification 63× and arranged into treatment groups with Photoshop
tools. The images were enhanced together in the same layer with
Photoshop automatic contrast and brightening tools. a. Untreated
control. b. Cytidine (15 μM)+3′-SL (15 μM)
Fig. 6 Effects of cytidine in combination with 3′-SL on melanocyte-
keratinocyte interactions and melanosome transfer. Cells were incubated
72 h with cytidine+3′-SL, fixed in paraformaldehyde, stained for melanin
with the Fontana-Masson silver stain. Images were photographed and
arranged into treatment groups with Photoshop tools. The images were
enhanced together in the same layer with Photoshop automatic contrast
and brightening tools. a. Untreated control. b. Cytidine (15 μM)+3′-SL
(15 μM) (c). 6′-SL (15 μM); (d). 3′-SL (15 μM). Magnification 63×
Table 2 Minimal treatment concentrations for >80 % reduction in
melanin content
Treatment Minimal concentration for >80 % inhibition






Cytidine+6′-SL 15 μm+15 μM
Cytidine+3′-SL 15 μm+15 μΜ
6′-SL+3′-SL 5 μm+5 μM
Data are from Fig. 5a
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bark lectin (1:800) (Vector Labs, Burlingame, CA) for 30 min
at RT. Following a wash in 1× PBS, the cells were incubated
with vectastain ABC-AP (Vector Labs) complex for 30 min at
RT. The ABC-AP complex was prepared fresh according to
the instructions provided with the vectastain ABC-AP kit. The
cells were washed in 1× PBS to remove the ABC-AP complex
and incubated with fast red chromagen staining solution
(Dako) for 10′ at RT. The cells were rinsed in water and incu-
bated with gill free hematoxylin for 5′. The slides were rinsed
in H2O followed by a gentle wash with 0.5 % ammonium
hydroxide. The slides were air dried and mounted on cover
slips and the images were captured in tiff format using fluo-
rescence microscope (Nikon) and analyzed.
Fontana-Masson silver stain for melanin Silver staining for
melanin was performed according to the instructions provided
with the Fontana-Masson staining kit (American MasterTech,
Lodi, CA). Cells grown in collagen-coated chamber slides
were fixed in 4 % PFA and rinsed with water for 5′ to remove
traces of PBS. Slides were then placed in ammonical silver
solution followed by incubation in solutions of 0.1 % gold
chloride, 5 % sodium thiosulfate, rinsed in running tap water
to remove the staining solution and dehydrated through 3
changes of fresh absolute alcohol. Cleared slides were rinsed
through 3 changes of fresh xylene and coverslips were applied
with mounting medium.
Transfection of siRNA’s Mouse melan-A cells and human
darkly pigmented (DP) melanocytes were added at 8×104
cells/well in a 24 well plate and incubated for 24 h at 37 ° C.
Theywere then transfected with ST6 and ST3 siRNAs accord-
ing to the RNAiFect Transfection Handbook (Qiagen). Brief-
ly, 1 μg each of siRNA ST6 and siRNA ST3 was added to
RNAi Fect transfection reagent at dilutions of 1:3 and 1:6,
complexed with 3 μl and 6 μl of the RNAiFect in 100 μl of
culture medium, incubated for 10–15 min with Melan-A and
DP cells in triplicate wells at room temperature and then an
additional 24 h at 37 ° C. The cultures were rinsed, fresh
culture medium was added and the cells were incubated an
additional 24 h at 37 °C. The experiment was stopped by
discarding the culture medium andwashing with 1× PBS three
times. The cells were then treated with lysis buffer and mela-
nin was isolated by alkaline hydrolysis and quantified by ab-
sorbance at 490 nM.
Treatment with inhibitors Cells were plated on 24-well
plates at 2×105 cells/well and treated with various inhibitors
in triplicate. Media were replaced with fresh inhibitor-
containing media every 24 h. After 3 days, cells were lysed
with cell lysis buffer containing protease inhibitor cocktail and
PMSF (phenylmethyl sulfonyl fluoride) (Invitrogen) and in-
cubated 20’min on ice. The lysed cells were centrifuged at 10,
000 rpm for 10 ′. The supernatants were saved for
Fig. 8 Effects of siRNAs for ST6
and ST3 on melanin content and
tyrosinase activity in cultured
human melanocytes. UT=
untreated control; ST3 siRNA
1:6; ST3 siRNA 1:3; ST6 siRNA
1:6; ST6 siRNA 1:3
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measurement of dopa oxidase activity and the pellets were
evaluated for melanin content.
Dopa oxidase assay Reactionmixture contained 20μL of the
lysate supernatant, 20 μl of 10 mML-Dopa in 160 μl of
50 mM sodium phosphate buffer (0.1 M, pH6.8) Samples
were transferred in triplicate to 96-well plates and evaluated
for the formation of dopachrome by reading the absorbance at
475 nm for 30′ at 1′ intervals on an M5 microplate reader
(ThermoScientific, Waltham, MA). The slope derived from
the kinetics was used to calculate the % dopa oxidase/
tyrosinase activity in treated wells relative to the untreated
controls.
Melanin assay Melanin was extracted following the proce-
dure of Ni-Komatsu, et al., (2005). In brief, the growth medi-
um was removed and the cells lysed as above. The lysed cells
were centrifuged and the pellet was washed with ethanol:ether
(1:1) solution and then solubilized in 100 μl 20 % DMSO in
2 N NaOH. The melanin extracts (100 μL) were transferred to
a 96-well plate and total melanin content was quantitated with
a M5 Spectramax plate reader at 490 nm.
Photography and image processing Representative fields of
cultured cells were photographed with a Zeiss Axioskop 40
light microscope equipped with a Spot Flex digital camera.
Using Photoshop tools, areas of interest were cut and pasted
into the treatment groups herein. For a given figure, any com-
posite images were enhanced together, in a single layer, with
automatic contrast and brightening tools.
Statistics Dose response curves were assessed for Bliss Addi-
tivity and synergism. For comparisons of melanin content and
tyrosinase/dopa oxidase activity in treated vs. untreated cultures,
P-values were determined by the Welch Two Sample t-test.
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